{"entity":{"id":"nct02260817","kind":"trial","name":"Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer","aka":[],"tldr":"A phase 3 trial of Choline C-11 in Prostate cancer, run by Global Isotopes, LLC d/b/a Zevacor Molecular, completed.","summary":"Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer is a phase 3 interventional study registered as NCT02260817 by Global Isotopes, LLC d/b/a Zevacor Molecular, with 109 participants recorded, started 2014-10 and reaching its primary completion in 2016-06. Interventions recorded: 11C-choline Injection. Conditions recorded: Metastatic Prostate Cancer.\n\nLinked to the drug Choline C-11 because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT02260817","url":"https://clinicaltrials.gov/study/NCT02260817"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":["choline-c11"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02260817","phase":"3","setting":"Expanded Access to 11C Choline PET/CT and 11C Choline PET/MR for Staging of Recurrent Prostate Cancer With Comparison Study of CT and MR Modalities","sponsor":"Global Isotopes, LLC d/b/a Zevacor Molecular","enrolled":109,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02260817/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"choline-c11","kind":"drug","name":"Choline C-11","route":"/drugs/choline-c11/"}]}}